Heier Jeffrey S. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Heier Jeffrey S. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $229K.

Profile

Heier Jeffrey S.

Jeffrey S. Heier is the Chief Scientific Officer at Ocular Therapeutix, Inc., a biotechnology company focused on developing therapies for eye diseases. He has been involved in multiple SEC filings related to his role at the company.

RoleChief Scientific Officer
Notability20/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-28OCULOCULAR THERAPEUTIX, INCS — Open-market sale3.0K$8.20$25K
2026-02-25OCULOCULAR THERAPEUTIX, INCS — Open-market sale3.1K$8.28$25K
2025-10-02OCULOCULAR THERAPEUTIX, INCS — Open-market sale10.5K$11.04$116K
2025-08-25OCULOCULAR THERAPEUTIX, INCS — Open-market sale3.1K$12.04$37K
2024-11-27OCULOCULAR THERAPEUTIX, INCS — Open-market sale2.9K$9.01$27K
2024-10-04OCULOCULAR THERAPEUTIX, INCA — Grant or award100.0K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Heier Jeffrey S.?

Jeffrey S. Heier is the Chief Scientific Officer at Ocular Therapeutix, Inc., a biotechnology company focused on developing therapies for eye diseases. He has been involved in multiple SEC filings related to his role at the company.…

How many SEC Form 4 filings has Heier Jeffrey S. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Heier Jeffrey S. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 5 open-market sales ($229K) across all tracked filings.

Where can I see all of Heier Jeffrey S.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Heier Jeffrey S. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.